GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioton BIO.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

3.49

+0.87%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

PLN 282.5m

FY2016FY2025

Net income

PLN 3.4m

FY2016FY2025

Free cash flow

PLN 2.3m

FY2016FY2025

Shareholders' equity

PLN 594.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenuePLN 282.5mPLN 207.8mPLN 181.6mPLN 233.2mPLN 163.0mPLN 221.8mPLN 202.0mPLN 241.2mPLN 361.6mPLN 277.6m
Gross profitPLN 96.7mPLN 64.8mPLN 72.9mPLN 95.8mPLN 76.3mPLN 104.7mPLN 102.2mPLN 116.1mPLN 186.3mPLN 138.0m
Research and developmentPLN 4.0mPLN 4.0mPLN 5.5mPLN 5.3mPLN 4.7mPLN 4.0mPLN 6.8mPLN 33.0mPLN 8.9mPLN 7.6m
Operating incomePLN 12.8m−PLN 5.7mPLN 15.7mPLN 13.4mPLN 19.0mPLN 48.6m−PLN 154.4mPLN 23.2mPLN 18.0m−PLN 13.9m
Net incomePLN 3.4m−PLN 15.7mPLN 2.3mPLN 1.4mPLN 2.9mPLN 33.9m−PLN 126.7mPLN 26.3m−PLN 7.3m−PLN 28.6m
Diluted earnings per share0.04-0.180.030.020.030.40-1.480.31-0.08-0.33

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 764.6mPLN 794.1mPLN 822.2mPLN 810.3mPLN 865.2mPLN 867.1mPLN 881.4mPLN 1.01bnPLN 1.14bnPLN 1.30bn
Cash and short-term investmentsPLN 8.3mPLN 7.0mPLN 3.9mPLN 9.3mPLN 8.9mPLN 22.2mPLN 7.2mPLN 7.7mPLN 38.7mPLN 88.6m
Total liabilitiesPLN 170.6mPLN 203.6mPLN 215.9mPLN 204.3mPLN 242.4mPLN 247.5mPLN 299.4mPLN 297.2mPLN 368.7mPLN 481.4m
DebtPLN 57.2mPLN 56.6mPLN 68.7mPLN 76.4mPLN 110.1mPLN 110.1mPLN 127.4mPLN 111.6mPLN 198.2mPLN 229.2m
Shareholders' equityPLN 594.0mPLN 590.5mPLN 606.4mPLN 606.1mPLN 604.5mPLN 619.6mPLN 582.0mPLN 712.8mPLN 788.8mPLN 831.0m
Shares outstanding86m86m86m86m86m86m86m86m86m86m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsPLN 15.3mPLN 36.3mPLN 39.6mPLN 56.1mPLN 5.5mPLN 41.9mPLN 46.7mPLN 27.9mPLN 17.5mPLN 23.1m
Capital spending−PLN 13.1m−PLN 11.6m−PLN 44.2m−PLN 29.6m−PLN 12.9m−PLN 4.7m−PLN 53.5m−PLN 43.4m−PLN 33.7m−PLN 24.4m
Free cash flowPLN 2.3mPLN 24.7m−PLN 4.5mPLN 26.5m−PLN 7.4mPLN 37.3m−PLN 6.8m−PLN 15.6m−PLN 16.2m−PLN 1.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 71.1mPLN 49.1mPLN 64.4mPLN 72.7mPLN 79.9mPLN 65.6mPLN 77.7mPLN 42.0m
Gross profitPLN 31.1mPLN 16.1mPLN 25.8mPLN 26.9mPLN 26.3mPLN 13.8mPLN 21.8mPLN 14.4m
Operating incomePLN 7.9m−PLN 5.4mPLN 5.0mPLN 8.0mPLN 6.3m−PLN 4.1mPLN 3.1m−PLN 2.0m
Net income−PLN 9.2m−PLN 5.2mPLN 1.8mPLN 4.2mPLN 3.2m−PLN 5.8m−PLN 4.5m−PLN 3.4m
Diluted earnings per share-0.11-0.060.020.050.04-0.07-0.05-0.04
Cash from operations−PLN 3.0m——PLN 2.0mPLN 9.0mPLN 5.0mPLN 12.0mPLN 4.0m
Capital spending−PLN 6.0m−PLN 3.0m−PLN 6.0m—−PLN 2.0m−PLN 4.0m−PLN 2.0m—
Free cash flow−PLN 9.0m———PLN 7.0mPLN 1.0mPLN 10.0m—
Total assetsPLN 771.9mPLN 768.5mPLN 764.6mPLN 760.9mPLN 763.8mPLN 768.7mPLN 794.1mPLN 790.4m
Cash and short-term investmentsPLN 1.3mPLN 2.6mPLN 8.3mPLN 1.6mPLN 1.4mPLN 2.7mPLN 7.0mPLN 623,000
DebtPLN 53.0mPLN 43.9mPLN 47.6mPLN 23.4mPLN 31.8mPLN 36.9mPLN 42.9mPLN 43.3m
Shareholders' equityPLN 579.5mPLN 588.8mPLN 594.0mPLN 592.1mPLN 588.0mPLN 584.8mPLN 590.5mPLN 595.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.6%5.0%-3.5%
Operating income-1.5%-23.4%—
Net income33.7%-36.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.0%36.5%39.6%44.0%
Operating margin1.4%4.0%8.0%-19.0%
Net margin-2.5%-0.9%2.2%-22.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings97.7-15.8134.7203.6124.711.0-2.616.5-41.2-24.6
Price to sales1.21.21.71.22.21.71.61.80.82.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 14 Jan 2014
  • 5-for-1 split · 26 Jun 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.